Eph/ephrin signalling and function in oncogenesis: Lessons from embryonic development

Current Cancer Drug Targets

Volumn 8, Issue 6, 2008, Pages 473-489

  Janes, Peter W ^a   Adikari, Samantha ^a   Lackmann, Martin ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiogenesis; Cell positioning; Colorectal cancer; Eph receptor tyrosine kinases; Ephrins; Melanoma; Somitogenesis; Tumor progression

Indexed keywords

BETA CATENIN; EPHRIN; EPHRIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE KINASE RECEPTOR; WNT PROTEIN;

ANGIOGENESIS; CANCER THERAPY; CARCINOGENESIS; CARDIOVASCULAR SYSTEM; CELL INTERACTION; CELL MIGRATION; COLORECTAL CANCER; DRUG TARGETING; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EPITHELIUM CELL; EPITHELIUM TUMOR; LIGAND BINDING; MELANOMA; MESENCHYME CELL; MORPHOGENESIS; NONHUMAN; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SOMITE; TUMOR GROWTH;

ANIMALS; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; EMBRYONIC DEVELOPMENT; EPHRINS; GERM CELLS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, EPH FAMILY; SIGNAL TRANSDUCTION;

EID: 51349144056     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800908785699315     Document Type: Review

References (267)

1. Hunter, T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 1998, 353(1368), 583-605.
2. Hirai, H.; Maru, Y.; Hagiwara, K.; Nishida, J.; Takaku, F. A novel putative tyrosine kinase receptor encoded by the eph gene. Science 1987, 238(4834), 1717-1720.
3. Boyd, A. W.; Lackmann, M. Signals from Eph and ephrin proteins: a developmental tool kit. Sci. STKE. 2001, 2001(112), RE20.
4. Pasquale, E. B. Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell. Biol. 2005, 6(6), 462-475.
5. Poliakov, A.; Cotrina, M.; Wilkinson, D. G. Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev. Cell. 2004, 7(4), 465-480.
6. Conover, J. C.; Doetsch, F.; Garcia-Verdugo, J. M.; Gale, N. W.; Yancopoulos, G. D.; Alvarez-Buylla, A. Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone. Nat. Neurosci. 2000, 3(11), 1091-1097.
7. Gerlai, R. Eph receptors and neural plasticity. Nat. Rev. Neurosci. 2001, 2(3), 205-209.
8. Holmberg, J.; Armulik, A.; Senti, K. A.; Edoff, K.; Spalding, K.; Momma, S.; Cassidy, R.; Flanagan, J. G.; Frisen, J. Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis. Genes Dev. 2005, 19(4), 462-471.
9. Noren, N. K.; Pasquale, E. B. Paradoxes of the EphB4 receptor in cancer. Cancer Res. 2007, 67(9), 3994-3997.
10. Suga, H.; Koyanagi, M.; Hoshiyama, D.; Ono, K.; Iwabe, N.; Kuma, K.; Miyata, T. Extensive gene duplication in the early evolution of animals before the parazoan-eumetazoan split demonstrated by G proteins and protein tyrosine kinases from sponge and hydra. J. Mol. Evol. 1999, 48(6), 646-653.
11. Drescher, U. Eph family functions from an evolutionary perspective. Curr. Opin. Genet. Dev. 2002, 12(4), 397-402.
12. George, S. E.; Simokat, K.; Hardin, J.; Chisholm, A.D. The VAB-1 Eph receptor tyrosine kinase functions in neural and epithelial morphogenesis in C. elegans. Cell 1998, 92(5), 633-643.
13. Wang, X.; Roy, P. J.; Holland, S. J.; Zhang, L. W.; Culotti, J. G.; Pawson, T. Multiple ephrins control cell organization in C. elegans using kinase-dependent and -independent functions of the VAB-1 Eph receptor. Mol. Cell. 1999, 4(6), 903-913.
14. Mohamed, A. M.; Chin-Sang, I. D. Characterization of loss-of-function and gain-of-function Eph receptor tyrosine kinase signaling in C. elegans axon targeting and cell migration. Dev. Biol. 2006, 290(1), 164-176.
15. Marston, D. J.; Goldstein, B. Actin-based forces driving embryonic morphogenesis in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 2006, 16(4), 392-398.
16. Gale, N. W.; Holland, S. J.; Valenzuela, D. M.; Flenniken, A.; Pan, L.; Ryan, T. E.; Henkemeyer, M.; Strebhardt, K.; Hirai, H.; Wilkinson, D. G.; Pawson, T.; Davis, S.; Yancopoulos, G. D. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 1996, 17(1), 9-19.
17. Winning, R. S.; Scales, J. B.; Sargent, T. D. Disruption of cell adhesion in Xenopus embryos by Pagliaccio, an Eph- class receptor tyrosine kinase. Dev. Biol. 1996, 179(2), 309-319.
18. Jones, T. L.; Chong, L. D.; Kim, J.; Xu, R. H.; Kung, H. F.; Daar, I. O. Loss of cell adhesion in Xenopus laevis embryos mediated by the cytoplasmic domain of XLerk, an erythropoietin-producing hepatocellular ligand. Proc. Natl. Acad. Sci. USA 1998, 95(2), 576-581.
19. Oates, A. C.; Lackmann, M.; Power, M. A.; Brennan, C.; Down, L. M.; Do, C.; Evans, B.; Holder, N.; Boyd, A. W. An early developmental role for eph-ephrin interaction during vertebrate gastrulation. Mech. Dev. 1999, 83(1-2), 77-94.
20. Durbin, L.; Sordino, P.; Barrios, A.; Gering, M.; Thisse, C.; Thisse, B.; Brennan, C.; Green, A.; Wilson, S.; Holder, N. Anteroposterior patterning is required within segments for somite boundary formation in developing zebrafish. Development 2000, 127(8), 1703-1713.
21. Barrios, A.; Poole, R. J.; Durbin, L.; Brennan, C.; Holder, N.; Wilson, S. W. Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis. Curr. Biol. 2003, 13(18), 1571-1582.
22. Koshida, S.; Kishimoto, Y.; Ustumi, H.; Shimizu, T.; Furutani-Seiki, M.; Kondoh, H.; Takada, S. Integrinalpha5-dependent fibronectin accumulation for maintenance of somite boundaries in zebrafish embryos. Dev. Cell. 2005, 8(4), 587-598.
23. Compagni, A.; Logan, M.; Klein, R.; Adams, R. H. Control of skeletal patterning by ephrinB1-EphB interactions. Dev. Cell. 2003, 5(2), 217-230.
24. Davy, A.; Aubin, J.; Soriano, P. Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev. 2004, 18(5), 572-583.
25. Flanagan, J. G. Neural map specification by gradients. Curr. Opin. Neurobiol. 2006, 16(1), 59-66.
26. Lemke, G.; Reber, M. Retinotectal mapping: new insights from molecular genetics. Annu. Rev. Cell. Dev. Biol. 2005, 21, 551-580.
27. Adams, R. H. Vascular patterning by Eph receptor tyrosine kinases and ephrins. Semin. Cell. Dev. Biol. 2002, 13(1), 55-60.
28. Kuijper, S.; Turner, C. J.; Adams, R. H. Regulation of angiogenesis by Eph-ephrin interactions. Trends. Cardiovasc. Med. 2007, 17(5), 145-151.
29. Helbling, P. M.; Saulnier, D. M.; Brandli, A. W. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. Development 2000, 127(2), 269-278.
30. Swartz, M. E.; Eberhart, J.; Pasquale, E. B.; Krull, C. E. EphA4/ephrin-A5 interactions in muscle precursor cell migration in the avian forelimb. Development 2001, 128(23), 4669-4680.
31. Oike, Y.; Ito, Y.; Hamada, K.; Zhang, X. Q.; Miyata, K.; Arai, F.; Inada, T.; Araki, K.; Nakagata, N.; Takeya, M.; Kisanuki, Y. Y.; Yanagisawa, M.; Gale, N. W.; Suda, T. Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. Blood 2002, 100(4), 1326-1333.
32. Kania, A.; Jessell, T. M. Topographic motor projections in the limb imposed by LIM homeodomain protein regulation of ephrin-A:EphA interactions. Neuron 2003, 38(4), 581-596.
33. Foo, S. S.; Turner, C. J.; Adams, S.; Compagni, A.; Aubyn, D.; Kogata, N.; Lindblom, P.; Shani, M.; Zicha, D.; Adams, R. H. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 2006, 124(1), 161-73.
34. Stephen, L. J.; Fawkes, A. L.; Verhoeve, A.; Lemke, G.; Brown, A. A critical role for the EphA3 receptor tyrosine kinase in heart development. Dev. Biol. 2007, 302(1), 66-79.
35. Dodelet, V. C.; Pasquale, E. B. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 2000, 19(49), 5614-5619.
36. Brantley-Sieders, D.; Schmidt, S.; Parker, M.; Chen, J. Eph receptor tyrosine kinases in tumor and tumor microenvironment. Curr. Pharm. Des. 2004, 10(27), 3431-3442.
37. Wimmer-Kleikamp, S. H.; Lackmann, M. Eph-modulated Cell Morphology, Adhesion and Motility in Carcinogenesis. IUBMB Life 2005, 57(6), 421-31.
38. Himanen, J. P.; Nikolov, D. B. Eph signaling: a structural view. Trends Neurosci. 2003, 26(1), 46-51.
39. Eph Nomenclature Committee Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 1997, 90, 403-404.
40. Himanen, J. P.; Chumley, M. J.; Lackmann, M.; Li, C.; Barton, W. A.; Jeffrey, P. D.; Vearing, C.; Geleick, D.; Feldheim, D. A.; Boyd, A. W.; Henkemeyer, M.; Nikolov, D. B. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat. Neurosci. 2004, 7(5), 501-509.
41. Lackmann, M.; Mann, R. J.; Kravets, L.; Smith, F. M.; Bucci, T. A.; Maxwell, K. F.; Howlett, G. J.; Olsson, J. E.; Vanden Bos, T.; Cerretti, D. P.; Boyd, A. W. Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor. J. Biol. Chem. 1997, 272(26), 16521-16530.
42. Cooke, J. E.; Kemp, H. A.; Moens, C. B. EphA4 is required for cell adhesion and rhombomere-boundary formation in the zebrafish. Curr. Biol. 2005, 15(6), 536-542.
43. Kullander, K.; Butt, S. J.; Lebret, J. M.; Lundfald, L.; Restrepo, C. E.; Rydstrom, A.; Klein, R.; Kiehn, O. Role of EphA4 and EphrinB3 in local neuronal circuits that control walking. Science 2003, 299(5614), 1889-1892.
44. Labrador, J. P.; Brambilla, R.; Klein, R. The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling. EMBO J. 1997, 16(13), 3889-3897.
45. Lackmann, M.; Oates, A. C.; Dottori, M.; Smith, F. M.; Do, C.; Power, M.; Kravets, L.; Boyd, A. W. Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization. J. Biol.Chem. 1998, 273(32), 20228-20237.
46. Himanen, J. P.; Rajashankar, K. R.; Lackmann, M.; Cowan, C. A.; Henkemeyer, M.; Nikolov, D. B. Crystal structure of an Eph receptor-ephrin complex. Nature 2001, 414(6866), 933-938.
47. Wimmer-Kleikamp, S. H.; Janes, P. W.; Squire, A.; Bastiaens, P. I.; Lackmann, M. Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J. Cell Biol. 2004, 164(5), 661-666.
48. Holland, S. J.; Gale, N. W.; Gish, G. D.; Roth, R. A.; Songyang, Z.; Cantley, L. C.; Henkemeyer, M.; Yancopoulos, G. D.; Pawson, T. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J. 1997, 16(13), 3877-3888.
49. Zisch, A. H.; Kalo, M. S.; Chong, L. D.; Pasquale, E. B. Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region. Oncogene 1998, 16(20), 2657-2670.
50. Wybenga-Groot, L. E.; Baskin, B.; Ong, S. H.; Tong, J.; Pawson, T.; Sicheri, F. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 2001, 106(6), 745-757.
51. Kullander, K.; Klein, R. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell. Biol. 2002, 3(7), 475-486.
52. Cowan, C. A.; Henkemeyer, M. Ephrins in reverse, park and drive. Trends Cell. Biol. 2002, 12(7), 339-346.
53. Davy, A.; Soriano, P. Ephrin signaling in vivo: look both ways. Dev. Dyn. 2005, 232(1), 1-10.
54. Egea, J.; Klein, R. Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell. Biol. 2007, 17(5), 230-238.
55. Klein, R. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr. Opin. Cell. Biol. 2004, 16(5), 580-589.
56. Zisch, A. H.; Pazzagli, C.; Freeman, A. L.; Schneller, M.; Hadman, M.; Smith, J. W.; Ruoslahti, E.; Pasquale, E. B. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses. Oncogene 2000, 19(2), 177-187.
57. Elowe, S.; Holland, S. J.; Kulkarni, S.; Pawson, T. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol. Cell. Biol. 2001, 21(21), 7429-7441.
58. Miao, H.; Wei, B. R.; Peehl, D. M.; Li, Q.; Alexandrou, T.; Schelling, J. R.; Rhim, J. S.; Sedor, J. R.; Burnett, E.; Wang, B. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat. Cell. Biol. 2001, 3(5), 527-530.
59. Pratt, R. L.; Kinch, M. S. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade. Oncogene 2002, 21(50), 7690-7699.
60. Tong, J.; Elowe, S.; Nash, P.; Pawson, T. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity. J. Biol. Chem. 2003, 278(8), 6111-6119.
61. Vindis, C.; Cerretti, D. P.; Daniel, T. O.; Huynh-Do, U. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis. J. Cell. Biol. 2003, 162(4), 661-671.
62. Sancho, E.; Batlle, E.; Clevers, H. Live and let die in the intestinal epithelium. Curr. Opin. Cell. Biol. 2003, 15(6), 763-770.
63. Halloran, M. C.; Wolman, M. A. Repulsion or adhesion: receptors make the call. Curr. Opin. Cell. Biol. 2006, 18(5), 533-540.
64. Clevers, H.; Batlle, E. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res. 2006, 66(1), 2-5.
65. Davis, S.; Gale, N. W.; Aldrich, T. H.; Maisonpierre, P. C.; Lhotak, V.; Pawson, T.; Goldfarb, M.; Yancopoulos, G. D. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 1994, 266(5186), 816-819.
66. Stein, E.; Lane, A. A.; Cerretti, D. P.; Schoecklmann, H. O.; Schroff, A. D.; Van Etten, R. L.; Daniel, T. O. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 1998, 12(5), 667-678.
67. Lawrenson, I. D.; Wimmer-Kleikamp, S. H.; Lock, P.; Schoenwaelder, S. M.; Down, M.; Boyd, A. W.; Alewood, P. F.; Lackmann, M. Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3- expressing 293T and melanoma cells by CrkII and Rhomediated signalling. J. Cell Sci. 2002, 115(Pt 5), 1059-1072.
68. Carter, N.; Nakamoto, T.; Hirai, H.; Hunter, T. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat. Cell. Biol. 2002, 4(8), 565-573.
69. Dobrzanski, P.; Hunter, K.; Jones-Bolin, S.; Chang, H.; Robinson, C.; Pritchard, S.; Zhao, H.; Ruggeri, B. Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res. 2004, 64(3), 910-919.
70. Smith, F. M.; Vearing, C.; Lackmann, M.; Treutlein, H.; Himanen, J.; Chen, K.; Saul, A.; Nikolov, D.; Boyd, A. W. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen. J. Biol. Chem. 2004, 279(10), 9522-9531.
71. Day, B.; To, C.; Himanen, J. P.; Smith, F. M.; Nikolov, D. B.; Boyd, A. W.; Lackmann, M. Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. J. Biol. Chem. 2005, 280(28), 26526-26532.
72. Marston, D. J.; Dickinson, S.; Nobes, C. D. Rac-dependent transendocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat. Cell. Biol. 2003, 5(10), 879-888.
73. Hattori, M.; Osterfield, M.; Flanagan, J. G. Regulated cleavage of a contact-mediated axon repellent. Science 2000, 289(5483), 1360-1365.
74. Zimmer, M.; Palmer, A.; Kohler, J.; Klein, R. EphB-ephrinB bidirectional endocytosis terminates adhesion allowing contact mediated repulsion. Nat. Cell. Biol. 2003, 5(10), 869-878.
75. Janes, P. W.; Saha, N.; Barton, W. A.; Kolev, M. V.; Wimmer-Kleikamp, S. H.; Nievergall, E.; Blobel, C. P.; Himanen, J. P.; Lackmann, M.; Nikolov, D. B. Adam Meets Eph: An ADAM Substrate Recognition Module Acts as a Molecular Switch for Ephrin Cleavage In trans. Cell 2005, 123(2), 291-304.
76. Xu, Z.; Lai, K. O.; Zhou, H. M.; Lin, S. C.; Ip, N. Y. Ephrin-B1 Reverse Signaling Activates JNK through a Novel Mechanism That Is Independent of Tyrosine Phosphorylation. J. Biol. Chem. 2003, 278(27), 24767-24775.
77. Egea, J.; Nissen, U. V.; Dufour, A.; Sahin, M.; Greer, P.; Kullander, K.; Mrsic-Flogel, T. D.; Greenberg, M. E.; Kiehn, O.; Vanderhaeghen, P.; Klein, R. Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron 2005, 47(4), 515-528.
78. Bouzioukh, F.; Wilkinson, G. A.; Adelmann, G.; Frotscher, M.; Stein, V.; Klein, R. Tyrosine phosphorylation sites in ephrinB2 are required for hippocampal long-term potentiation but not long-term depression. J. Neurosci. 2007, 27(42), 11279-11288.
79. Gu, C.; Park, S. The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol. Cell. Biol. 2001, 21(14), 4579-4597.
80. Matsuoka, H.; Obama, H.; Kelly, M. L.; Matsui, T.; Nakamoto, M. Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration. J. Biol. Chem. 2005, 280(32), 29355-29363.
81. Miao, H.; Strebhardt, K.; Pasquale, E. B.; Shen, T. L.; Guan, J. L.; Wang, B. Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase: Role of Rho family small GTPases. J. Biol. Chem. 2005, 280(2), 923-932
82. McLaughlin, T.; O'Leary, D. D. Molecular gradients and development of retinotopic maps. Annu. Rev. Neurosci. 2005, 28, 327-355.
83. Holmberg, J.; Frisen, J. Ephrins are not only unattractive. Trends Neurosci. 2002, 25(5), 239-243.
84. Holmberg, J.; Clarke, D. L.; Frisen, J. Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature 2000, 408(6809), 203-206.
85. Binns, K. L.; Taylor, P. P.; Sicheri, F.; Pawson, T.; Holland, S. J. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. Mol. Cell. Biol. 2000, 20(13), 4791-4805.
86. Wiesner, S.; Wybenga-Groot, L. E.; Warner, N.; Lin, H.; Pawson, T.; Forman-Kay, J. D.; Sicheri, F. A change in conformational dynamics underlies the activation of Eph receptor tyrosine kinases. EMBO J. 2006, 25(19), 4686-4696.
87. Wimmer-Kleikamp, S. H.; Nievergall, E.; Gegenbauer, K.; Adikari, S.; Mansour, M.; Yeadon, T.; Boyd, A. W.; Patani, N. R.; Lackmann, M. Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells. Blood 2008, Apr 2. [Epub ahead of print].
88. Park, S. The EphA8 Receptor Phosphorylates and Activates Low Molecular Weight Phosphotyrosine Protein Phosphatase in vitro. J. Biochem. Mol. Biol. 2003, 36(3), 288-293.
89. Chiarugi, P.; Taddei, M. L.; Schiavone, N.; Papucci, L.; Giannoni, E.; Fiaschi, T.; Capaccioli, S.; Raugei, G.; Ramponi, G. LMW-PTP is a positive regulator of tumor onset and growth. Oncogene 2004, 23(22), 3905-3914.
90. Miao, H.; Burnett, E.; Kinch, M.; Simon, E.; Wang, B. Activation of EphA2 kinase suppresses integrin function and causes focaladhesion-kinase dephosphorylation. Nat.Cell. Biol. 2000, 2(2), 62-69.
91. Shintani, T.; Ihara, M.; Sakuta, H.; Takahashi, H.; Watakabe, I.; Noda, M. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O. Nat. Neurosci. 2006, 9(6), 761-769.
92. Kikawa, K. D.; Vidale, D. R.; Van Etten, R. L.; Kinch, M. S. Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J. Biol. Chem. 2002, 277(42), 39274-39279.
93. Zantek, N. D.; Azimi, M.; Fedor-Chaiken, M.; Wang, B.; Brackenbury, R.; Kinch, M.S. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell. Growth. Differ. 1999, 10(9), 629-638.
94. Zelinski, D. P.; Zantek, N. D.; Stewart, J. C.; Irizarry, A. R.; Kinch, M. S. EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res. 2001, 61(5), 2301-2306.
95. Palmer, A.; Zimmer, M.; Erdmann, K. S.; Eulenburg, V.; Porthin, A.; Heumann, R.; Deutsch, U.; Klein, R. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol. Cell. 2002, 9(4), 725-737.
96. Huynh-Do, U.; Stein, E.; Lane, A. A.; Liu, H.; Cerretti, D. P.; Daniel, T. O. Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins. EMBO J. 1999, 18(8), 2165-2173.
97. Hansen, M. J.; Dallal, G. E.; Flanagan, J. G. Retinal axon response to ephrin-as shows a graded, concentration-dependent transition from growth promotion to inhibition. Neuron 2004, 42(5), 717-730.
98. von Philipsborn, A. C.; Lang, S.; Bernard, A.; Loeschinger, J.; David, C.; Lehnert, D.; Bastmeyer, M.; Bonhoeffer, F. Microcontact printing of axon guidance molecules for generation of graded patterns. Nat. Protoc. 2006, 1(3), 1322-1328.
99. von Philipsborn, A. C.; Lang, S.; Loeschinger, J.; Bernard, A.; David, C.; Lehnert, D.; Bonhoeffer, F.; Bastmeyer, M. Growth cone navigation in substrate-bound ephrin gradients. Development 2006, 133(13), 2487-2495.
100. Reber, M.; Burrola, P.; Lemke, G. A relative signalling model for the formation of a topographic neural map. Nature 2004, 431(7010), 847-853.
101. Marquardt, T.; Shirasaki, R.; Ghosh, S.; Andrews, S. E.; Carter, N.; Hunter, T.; Pfaff, S.L. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 2005, 121(1), 127-139.
102. Carvalho, R. F.; Beutler, M.; Marler, K. J.; Knoll, B.; Becker-Barroso, E.; Heintzmann, R.; Ng, T.; Drescher, U. Silencing of EphA3 through a cis interaction with ephrinA5. Nat. Neurosci. 2006, 9(3), 322-330.
103. Irie, F.; Okuno, M.; Pasquale, E. B.; Yamaguchi, Y. EphrinB-EphB signalling regulates clathrin-mediated endocytosis through tyrosine phosphorylation of synaptojanin 1. Nat. Cell. Biol. 2005, 7(5), 501-509.
104. Hisata, S.; Sakisaka, T.; Baba, T.; Yamada, T.; Aoki, K.; Matsuda, M.; Takai, Y. Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes, leading to sustained activation of Rap1 and ERK and neurite outgrowth. J. Cell Biol. 2007, 178(5), 843-860.
105. Kheradmand, F.; Werb, Z. Shedding light on sheddases: role in growth and development. Bioessays 2002, 24(1), 8-12.
106. Seals, D. F.; Courtneidge, S. A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes. Dev. 2003, 17(1), 7-30.
107. Blobel, C. P. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell. Biol. 2005, 6(1), 32-43.
108. Pascall, J. C.; Brown, K. D. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem. Biophys. Res. Commun. 2004, 317(1), 244-252.
109. Georgakopoulos, A.; Litterst, C.; Ghersi, E.; Baki, L.; Xu, C.; Serban, G.; Robakis, N. K. Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J. 2006, 25(6), 1242-1252.
110. Noren, N. K.; Pasquale, E. B. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell. Signal. 2004, 16(6), 655-666.
111. Lawrenson, I. D.; Cody, S. H.; Lackmann, M. Morphological changes following Eph receptor stimulation. Trends. Cell. Biol.. 2001, 11(CD-ROM supplement,), GFP in Motion 2.
112. Takino, T.; Tamura, M.; Miyamori, H.; Araki, M.; Matsumoto, K.; Sato, H.; Yamada, K. M. Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration. J. Cell. Sci. 2003, 116(Pt 15), 3145-3155.
113. Nagashima, K.; Endo, A.; Ogita, H.; Kawana, A.; Yamagishi, A.; Kitabatake, A.; Matsuda, M.; Mochizuki, N. Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol. Biol. Cell. 2002, 13(12), 4231-4242.
114. Smith, L. M.; Walsh, P. T.; Rudiger, T.; Cotter, T. G.; Mc Carthy, T. V.; Marx, A.; O'Connor, R. EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion. Exp. Cell. Res. 2004, 292(2), 295-303.
115. Noren, N. K.; Foos, G.; Hauser, C. A.; Pasquale, E. B. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat. Cell. Biol. 2006, 8(8), 815-825.
116. Stein, E.; Huynh-Do, U.; Lane, A. A.; Cerretti, D. P.; Daniel, T. O. Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase. J. Biol. Chem. 1998, 273(3), 1303-1308.
117. Hock, B.; Bohme, B.; Karn, T.; Feller, S.; Rubsamen-Waigmann, H.; Strebhardt, K. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multidocking site for SH2-domain mediated interactions. Oncogene 1998, 17(2), 255-260.
118. Ellis, C.; Kasmi, F.; Ganju, P.; Walls, E.; Panayotou, G.; Reith, A. D. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn. Oncogene 1996, 12(8), 1727-1736.
119. Choi, S.; Park, S. Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity. Oncogene 1999, 18(39), 5413-5422.
120. Prevost, N.; Woulfe, D.; Tanaka, T.; Brass, L. F. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc. Natl. Acad. Sci. USA 2002, 99(14), 9219-9224.
121. Zou, J. X.; Liu, Y.; Pasquale, E. B.; Ruoslahti, E. Activated SRC oncogene phosphorylates R-ras and suppresses integrin activity. J. Biol. Chem. 2002, 277(3), 1824-1827.
122. Steinle, J. J.; Meininger, C. J.; Forough, R.; Wu, G.; Wu, M. H.; Granger, H. J. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 2002, 277(46), 43830-43835.
123. Zou, J. X.; Wang, B.; Kalo, M. S.; Zisch, A. H.; Pasquale, E. B.; Ruoslahti, E. An Eph receptor regulates integrin activity through RRas. Proc. Natl. Acad. Sci. USA 1999, 96(24), 13813-13818.
124. Dodelet, V. C.; Pazzagli, C.; Zisch, A. H.; Hauser, C. A.; Pasquale, E. B. A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A. J. Biol. Chem. 1999, 274(45), 31941-31946.
125. Nakada, M.; Niska, J. A.; Tran, N. L.; McDonough, W. S.; Berens, M. E. EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am. J. Pathol. 2005, 167(2), 565-576.
126. Becker, E.; Huynh-Do, U.; Holland, S.; Pawson, T.; Daniel, T. O.; Skolnik, E. Y. Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation. Mol. Cell. Biol. 2000, 20(5), 1537-1545.
127. Stein, E.; Cerretti, D. P.; Daniel, T. O. Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells. J. Biol. Chem. 1996, 271(38), 23588-23593.
128. Han, D. C.; Shen, T. L.; Miao, H.; Wang, B.; Guan, J. L. EphB1 associates with Grb7 and regulates cell migration. J. Biol. Chem. 2002, 277(47), 45655-45661.
129. Aasheim, H. C.; Delabie, J.; Finne, E. F. Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2. Blood 2005, 105(7), 2869-2876.
130. Moeller, M. L.; Shi, Y.; Reichardt, L. F.; Ethell, I. M. EphB receptors regulate dendritic spine morphogenesis through the recruitment/phosphorylation of focal adhesion kinase and RhoA activation. J. Biol. Chem. 2006, 281(3), 1587-1598.
131. Yu, H. H.; Zisch, A. H.; Dodelet, V. C.; Pasquale, E. B. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor. Oncogene 2001, 20(30), 3995-4006.
132. Pandey, A.; Lazar, D. F.; Saltiel, A. R.; Dixit, V. M. Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity. J. Biol. Chem. 1994, 269(48), 30154-30157.
133. Jimenez, C.; Jones, D. R.; Rodriguez-Viciana, P.; Gonzalez-Garcia, A.; Leonardo, E.; Wennstrom, S.; von Kobbe, C.; Toran, J. L.; RBorlado, L.; Calvo, V.; Copin, S. G.; Albar, J. P.; Gaspar, M. L.; Diez, E.; Marcos, M. A.; Downward, J.; Martinez, A. C.; Merida, I.; Carrera, A. C. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J. 1998, 17(3), 743-753.
134. Brantley-Sieders, D. M.; Caughron, J.; Hicks, D.; Pozzi, A.; Ruiz, J.C.; Chen, J. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J. Cell. Sci. 2004, 117(Pt 10), 2037-2049.
135. Zhuang, G.; Hunter, S.; Hwang, Y.; Chen, J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation. J. Biol. Chem. 2007, 282(4), 2683-2694.
136. Van Haastert, P. J.; Devreotes, P. N. Chemotaxis: signalling the way forward. Nat. Rev. Mol. Cell. Biol. 2004, 5(8), 626-634.
137. Klemke, R. L.; Leng, J.; Molander, R.; Brooks, P. C.; Vuori, K.; Cheresh, D. A. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J. Cell. Biol. 1998, 140(4), 961-972.
138. Lamorte, L.; Kamikura, D. M.; Park, M. A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein. Oncogene 2000, 19(52), 5973-5981.
139. Kain, K. H.; Klemke, R. L. Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. J. Biol. Chem. 2001, 276(19), 16185-16192.
140. Bouton, A. H.; Riggins, R. B.; Bruce-Staskal, P. J. Functions of the adapter protein Cas: signal convergence and the determination of cellular responses. Oncogene 2001, 20(44), 6448-6458.
141. Sharfe, N.; Freywald, A.; Toro, A.; Roifman, C. M. Ephrin-A1 Induces c-Cbl Phosphorylation and EphA Receptor Down-Regulation in T Cells. J. Immunol. 2003, 170(12), 6024-6032.
142. Groeger, G.; Nobes, C. D. Co-operative Cdc42 and Rho signalling mediates ephrinB-triggered endothelial cell retraction. Biochem. J. 2007, 404(1), 23-29.
143. Shamah, S. M.; Lin, M. Z.; Goldberg, J. L.; Estrach, S.; Sahin, M.; Hu, L.; Bazalakova, M.; Neve, R. L.; Corfas, G.; Debant, A.; Greenberg, M. E. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 2001, 105(2), 233-244.
144. Sahin, M.; Greer, P. L.; Lin, M. Z.; Poucher, H.; Eberhart, J.; Schmidt, S.; Wright, T. M.; Shamah, S. M.; O'Connell, S.; Cowan, C.W.; Hu, L.; Goldberg, J. L.; Debant, A.; Corfas, G.; Krull, C. E.; Greenberg, M.E. Eph-dependent tyrosine phosphorylation of ephexin1 modulates growth cone collapse. Neuron 2005, 46(2), 191-204.
145. Iwasato, T.; Katoh, H.; Nishimaru, H.; Ishikawa, Y.; Inoue, H.; Saito, Y. M.; Ando, R.; Iwama, M.; Takahashi, R.; Negishi, M.; Itohara, S. Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling. Cell 2007, 130(4), 742-753.
146. Banyard, J.; Anand-Apte, B.; Symons, M.; Zetter, B. R. Motility and invasion are differentially modulated by Rho family GTPases. Oncogene 2000, 19(4), 580-591.
147. Kleer, C. G.; van Golen, K. L.; Zhang, Y.; Wu, Z. F.; Rubin, M. A.; Merajver, S. D. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol. 2002, 160(2), 579-584.
148. Sahai, E.; Marshall, C. J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2(2), 133-142.
149. Murai, K. K.; Pasquale, E. B. 'Eph'ective signaling: forward, reverse and crosstalk. J. Cell. Sci. 2003, 116(Pt 14), 2823-2832.
150. Davy, A.; Gale, N. W.; Murray, E. W.; Klinghoffer, R. A.; Soriano, P.; Feuerstein, C.; Robbins, S. M. Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion. Genes. Dev. 1999, 13(23), 3125-3135.
151. Gauthier, L. R.; Robbins, S. M. Ephrin signaling: One raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them? Life Sci. 2003, 74(2-3), 207-216.
152. Krummel, M. F.; Davis, M. M. Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr. Opin. Immunol. 2002, 14(1), 66-74.
153. Hornberger, M. R.; Dutting, D.; Ciossek, T.; Yamada, T.; Handwerker, C.; Lang, S.; Weth, F.; Huf, J.; Wessel, R.; Logan, C.; Tanaka, H.; Drescher, U. Modulation of EphA receptor function by coexpressed ephrinA ligands on retinal ganglion cell axons. Neuron 1999, 22(4), 731-742.
154. Johnson, G. L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298(5600), 1911-1912.
155. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80(2), 179-185.
156. Hughes, P. E.; Pfaff, M. Integrin affinity modulation. Trends Cell. Biol. 1998, 8(9), 359-364.
157. Hughes, P. E.; Renshaw, M. W.; Pfaff, M.; Forsyth, J.; Keivens, V. M.; Schwartz, M. A.; Ginsberg, M. H. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 1997, 88(4), 521-530.
158. Chang, L.; Karin, M. Mammalian MAP kinase signalling cascades. Nature 2001, 410(6824), 37-40.
159. Corrigan, C.; Subramanian, R.; Miller, M. A. Eph and NMDA receptors control Ca2+/calmodulin-dependent protein kinase II activation during C. elegans oocyte meiotic maturation. Development 2005, 132(23), 5225-5237.
160. Miller, M. A.; Ruest, P. J.; Kosinski, M.; Hanks, S. K.; Greenstein, D. An Eph receptor sperm-sensing control mechanism for oocyte meiotic maturation in Caenorhabditis elegans. Genes Dev. 2003, 17(2), 187-200.
161. Nateri, A. S.; Raivich, G.; Gebhardt, C.; Da Costa, C.; Naumann, H.; Vreugdenhil, M.; Makwana, M.; Brandner, S.; Adams, R. H.; Jefferys, J.G.; Kann, O.; Behrens, A. ERK activation causes epilepsy by stimulating NMDA receptor activity. EMBO J. 2007, 26(23), 4891-4901.
162. van de Wetering, M.; Sancho, E.; Verweij, C.; de Lau, W.; Oving, I.; Hurlstone, A.; van der Horn, K.; Batlle, E.; Coudreuse, D.; Haramis, A. P.; Tjon-Pon-Fong, M.; Moerer, P.; van den Born, M.; Soete, G.; Pals, S.; Eilers, M.; Medema, R.; Clevers, H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111(2), 241-250.
163. Batlle, E.; Henderson, J. T.; Beghtel, H.; van den Born, M. M.; Sancho, E.; Huls, G.; Meeldijk, J.; Robertson, J.; van de Wetering, M.; Pawson, T.; Clevers, H. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002, 111(2), 251-263.
164. Wilkinson, D. G. Multiple roles of EPH receptors and ephrins in neural development. Nat. Rev. Neurosci. 2001, 2(3), 155-164.
165. Nakamoto, M.; Bergemann, A. D. Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. Microsc. Res. Tech. 2002, 59(1), 58-67.
166. Mellitzer, G.; Xu, Q.; Wilkinson, D. G. Control of cell behaviour by signalling through Eph receptors and ephrins. Curr. Opin. Neurobiol. 2000, 10(3), 400-408.
167. Wilkinson, D. G. Eph receptors and ephrins: regulators of guidance and assembly. Int. Rev. Cytol. 2000, 196, 177-244.
168. Holder, N.; Klein, R. Eph receptors and ephrins: effectors of morphogenesis. Development 1999, 126(10), 2033-2044.
169. Xu, Q.; Mellitzer, G.; Wilkinson, D. G. Roles of Eph receptors and ephrins in segmental patterning. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2000, 355(1399), 993-1002.
170. Xu, Q.; Holder, N.; Patient, R.; Wilson, S. W. Spatially regulated expression of three receptor tyrosine kinase genes during gastrulation in the zebrafish. Development 1994, 120(2), 287-299.
171. Jones, T. L.; Chong, L. D.; Kim, J.; Xu, R. H.; Kung, H. F.; Daar, I. O. Loss of cell adhesion in Xenopus laevis embryos mediated by the cytoplasmic domain of XLerk, an erythropoietin-producing hepatocellular ligand. Proc. Natl. Acad. Sci. USA 1998, 95(2), 576-581.
172. Winning, R. S.; Wyman, T. L.; Walker, G. K. EphA4 activity causes cell shape change and a loss of cell polarity in Xenopus laevis embryos. Differentiation 2001, 68(2-3), 126-132.
173. Durbin, L.; Brennan, C.; Shiomi, K.; Cooke, J.; Barrios, A.; Shanmugalingam, S.; Guthrie, B.; Lindberg, R.; Holder, N. Eph signaling is required for segmentation and differentiation of the somites. Genes Dev. 1998, 12(19), 3096-3109.
174. Chan, J.; Mably, J. D.; Serluca, F.C.; Chen, J. N.; Goldstein, N. B.; Thomas, M. C.; Cleary, J. A.; Brennan, C.; Fishman, M. C.; Roberts, T. M. Morphogenesis of prechordal plate and notochord requires intact Eph/ephrin B signaling. Dev. Biol. 2001, 234(2), 470-482.
175. Dale, J. K.; Maroto, M.; Dequeant, M. L.; Malapert, P.; McGrew, M.; Pourquie, O. Periodic notch inhibition by lunatic fringe underlies the chick segmentation clock. Nature 2003, 421(6920), 275-278.
176. Mellitzer, G.; Xu, Q.; Wilkinson, D. G. Eph receptors and ephrins restrict cell intermingling and communication. Nature 1999, 400(6739), 77-81.
177. Xu, Q.; Alldus, G.; Holder, N.; Wilkinson, D. G. Expression of truncated Sek-1 receptor tyrosine kinase disrupts the segmental restriction of gene expression in the Xenopus and zebrafish hindbrain. Development 1995, 121(12), 4005-4016.
178. Xu, Q.; Alldus, G.; Macdonald, R.; Wilkinson, D. G.; Holder, N. Function of the Eph-related kinase rtk1 in patterning of the zebrafish forebrain. Nature 1996, 381(6580), 319-322.
179. Chong, S. W.; Jiang, Y. J. Off limits - integrins holding boundaries in somitogenesis. Trends. Cell. Biol. 2005, 15(9), 453-457.
180. Julich, D.; Geisler, R.; Holley, S. A. Integrinalpha5 and delta/notch signaling have complementary spatiotemporal requirements during zebrafish somitogenesis. Dev. Cell 2005, 8(4), 575-586.
181. Pandey, A.; Shao, H.; Marks, R. M.; Polverini, P. J.; Dixit, V. M. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 1995a, 268(5210), 567-569.
182. Daniel, T. O.; Stein, E.; Cerretti, D. P.; St John, P. L.; Robert, B.; Abrahamson, D. R. ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int. Suppl. 1996, 57, S73-S81.
183. Ogawa, K.; Pasqualini, R.; Lindberg, R. A.; Kain, R.; Freeman, A.L.; Pasquale, E.B. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 2000, 19(52), 6043-6052.
184. Wang, H. U.; Chen, Z. F.; Anderson, D. J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998, 93(5), 741-753.
185. Adams, R. H.; Wilkinson, G. A.; Weiss, C.; Diella, F.; Gale, N. W.; Deutsch, U.; Risau, W.; Klein, R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999, 13(3), 295-306.
186. Gerety, S. S.; Wang, H. U.; Chen, Z. F.; Anderson, D. J. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell. 1999, 4(3), 403-414.
187. Adams, R. H.; Klein, R. Eph receptors and ephrin ligands. essential mediators of vascular development. Trends Cardiovasc. Med. 2000, 10(5), 183-188.
188. Adams, R. H.; Diella, F.; Hennig, S.; Helmbacher, F.; Deutsch, U.; Klein, R. The Cytoplasmic Domain of the Ligand EphrinB2 Is Required for Vascular Morphogenesis but Not Cranial Neural Crest Migration. Cell 2001, 104(1), 57-69.
189. Cowan, C. A.; Yokoyama, N.; Saxena, A.; Chumley, M. J.; Silvany, R. E.; Baker, L. A.; Srivastava, D.; Henkemeyer, M. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev. Biol. 2004, 271(2), 263-271.
190. Gale, N. W.; Baluk, P.; Pan, L.; Kwan, M.; Holash, J.; DeChiara, T. M.; McDonald, D. M.; Yancopoulos, G. D. Ephrin-B2 Selectively Marks Arterial Vessels and Neovascularization Sites in the Adult, with Expression in Both Endothelial and Smooth- Muscle Cells. Dev. Biol. 2001, 230(2), 151-160.
191. Shin, D.; Garcia-Cardena, G.; Hayashi, S.; Gerety, S.; Asahara, T.; Stavrakis, G.; Isner, J.; Folkman, J.; Gimbrone, M. A., Jr.; Anderson, D. J. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev. Biol. 2001, 230(2), 139-150.
192. Gerety, S. S.; Anderson, D. J. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 2002, 129(6), 1397-1410.
193. Beckmann, M. P.; Cerretti, D. P.; Baum, P.; Vanden Bos, T.; James, L.; Farrah, T.; Kozlosky, C.; Hollingsworth, T.; Shilling, H.; Maraskovsky, E.; Fletcher, F.; Lhotak, V.; Pawsen, T.; Lyman, S.D. Molecular characterization of a family of ligands for ephrelated tyrosine kinase receptors. EMBO J. 1994, 13(16), 3757-3762.
194. Flanagan, J. G.; Vanderhaeghen, P. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 1998, 21, 309-345.
195. Li, Y. Y.; McTiernan, C. F.; Feldman, A. M. IL-1 beta alters the expression of the receptor tyrosine kinase gene r- EphA3 in neonatal rat cardiomyocytes. Am. J. Physiol. 1998, 274(1 Pt 2), H331-H341.
196. Bogenrieder, T.; Herlyn, M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003, 22(42), 6524-6536.
197. Friedl, P.; Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 2003, 3(5), 362-374.
198. Blume-Jensen, P.; Hunter, T. Oncogenic kinase signalling. Nature 2001, 411(6835), 355-365.
199. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell 2000, 100(1), 57-70.
200. Holmberg, J.; Genander, M.; Halford, M. M.; Anneren, C.; Sondell, M.; Chumley, M. J.; Silvany, R. E.; Henkemeyer, M.; Frisen, J. EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 2006, 125(6), 1151-1163.
201. Ricard, J.; Salinas, J.; Garcia, L.; Liebl, D. J. EphrinB3 regulates cell proliferation and survival in adult neurogenesis. Mol. Cell. Neurosci. 2006, 31(4), 713-722.
202. Nasreen, N.; Mohammed, K. A.; Lai, Y.; Antony, V. B. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM). Cancer Lett. 2007, 258(2), 215-222.
203. Surawska, H.; Ma, P. C.; Salgia, R. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev. 2004, 15(6), 419-433.
204. Hafner, C.; Schmitz, G.; Meyer, S.; Bataille, F.; Hau, P.; Langmann, T.; Dietmaier, W.; Landthaler, M.; Vogt, T. Differential Gene Expression of Eph Receptors and Ephrins in Various Benign Human Tissues and Cancers. Clin. Chem. 2004, 50(3), 490-499.
205. Heroult, M.; Schaffner, F.; Augustin, H. G. Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp. Cell. Res. 2006, 312(5), 642-650.
206. Nikolova, Z.; Djonov, V.; Zuercher, G.; Andres, A. C.; Ziemiecki, A. Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J. Cell. Sci. 1998, 111(Pt 18), 2741-2751.
207. Takai, N.; Miyazaki, T.; Fujisawa, K.; Nasu, K.; Miyakawa, I. Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer. Oncol. Rep. 2001, 8(3), 567-573.
208. Varelias, A.; Koblar, S. A.; Cowled, P. A.; Carter, C. D.; Clayer, M. Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis. Cancer 2002, 95(4), 862-869.
209. Zeng, G.; Hu, Z.; Kinch, M. S.; Pan, C. X.; Flockhart, D. A.; Kao, C.; Gardner, T. A.; Zhang, S.; Li, L.; Baldridge, L. A.; Koch, M. O.; Ulbright, T. M.; Eble, J. N.; Cheng, L. High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia. Am. J. Pathol. 2003, 163(6), 2271-2276.
210. Miyazaki, T.; Kato, H.; Fukuchi, M.; Nakajima, M.; Kuwano, H. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int. J. Cancer 2003, 103(5), 657-663.
211. Mao, W.; Luis, E.; Ross, S.; Silva, J.; Tan, C.; Crowley, C.; Chui, C.; Franz, G.; Senter, P.; Koeppen, H.; Polakis, P. EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer. Cancer Res. 2004, 64(3), 781-788.
212. Fox, B. P.; Kandpal, R. P. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem. Biophys. Res. Commun. 2004, 318(4), 882-892.
213. Nakada, M.; Niska, J. A.; Miyamori, H.; McDonough, W. S.; Wu, J.; Sato, H.; Berens, M. E. The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res. 2004, 64(9), 3179-3185.
214. Bardelli, A.; Parsons, D. W.; Silliman, N.; Ptak, J.; Szabo, S.; Saha, S.; Markowitz, S.; Willson, J. K.; Parmigiani, G.; Kinzler, K. W.; Vogelstein, B.; Velculescu, V. E. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 2003, 300(5621), 949.
215. Sjoblom, T.; Jones, S.; Wood, L. D.; Parsons, D. W.; Lin, J.; Barber, T. D.; Mandelker, D.; Leary, R. J.; Ptak, J.; Silliman, N.; Szabo, S.; Buckhaults, P.; Farrell, C.; Meeh, P.; Markowitz, S. D.; Willis, J.; Dawson, D.; Willson, J. K.; Gazdar, A. F.; Hartigan, J.; Wu, L.; Liu, C.; Parmigiani, G.; Park, B. H.; Bachman, K. E.; Papadopoulos, N.; Vogelstein, B.; Kinzler, K. W.; Velculescu, V. E. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314(5797), 268-274.
216. Balakrishnan, A.; Bleeker, F. E.; Lamba, S.; Rodolfo, M.; Daniotti, M.; Scarpa, A.; van Tilborg, A. A.; Leenstra, S.; Zanon, C.; Bardelli, A. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res. 2007, 67(8), 3545-3550.
217. Lin, J.; Gan, C. M.; Zhang, X.; Jones, S.; Sjoblom, T.; Wood, L. D.; Parsons, D. W.; Papadopoulos, N.; Kinzler, K. W.; Vogelstein, B.; Parmigiani, G.; Velculescu, V. E. A multidimensional analysis of genes mutated in breast and colorectal cancers. Genome Res. 2007, 17(9), 1304-1318.
218. Chiari, R.; Hames, G.; Stroobant, V.; Texier, C.; Maillere, B.; Boon, T.; Coulie, P. G. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules. Cancer Res. 2000, 60(17), 4855-4863.
219. Easty, D. J.; Bennett, D. C. Protein tyrosine kinases in malignant melanoma. Melanoma. Res. 2000, 10(5), 401-411.
220. Wykosky, J.; Gibo, D. M.; Stanton, C.; Debinski, W. EphA2 as a novel molecular marker and target in glioblastoma multiforme. Mol. Cancer. Res. 2005, 3(10), 541-551.
221. Hatano, M.; Eguchi, J.; Tatsumi, T.; Kuwashima, N.; Dusak, J. E.; Kinch, M. S.; Pollack, I. F.; Hamilton, R. L.; Storkus, W. J.; Okada, H. EphA2 as a glioma-associated antigen: a novel target for glioma vaccines. Neoplasia 2005, 7(8), 717-722.
222. Tanaka, M.; Kamata, R.; Takigahira, M.; Yanagihara, K.; Sakai, R. Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma. Am. J. Pathol. 2007, 171(1), 68-78.
223. Berclaz, G.; Andres, A. C.; Albrecht, D.; Dreher, E.; Ziemiecki, A.; Gusterson, B. A.; Crompton, M. R. Expression of the receptor protein tyrosine kinase myk-1/htk in normal and malignant mammary epithelium. Biochem. Biophys. Res. Commun. 1996, 226(3), 869-875.
224. Wu, Q.; Suo, Z.; Risberg, B.; Karlsson, M. G.; Villman, K.; Nesland, J. M. Expression of Ephb2 and Ephb4 in breast carcinoma. Pathol. Oncol. Res. 2004, 10(1), 26-33.
225. Liu, W.; Ahmad, S. A.; Jung, Y. D.; Reinmuth, N.; Fan, F.; Bucana, C. D.; Ellis, L. M. Coexpression of ephrin-Bs and their receptors in colon carcinoma. Cancer 2002, 94(4), 934-939.
226. Stephenson, S. A.; Slomka, S.; Douglas, E. L.; Hewett, P. J.; Hardingham, J. E. Receptor protein tyrosine kinase EphB4 is upregulated in colon cancer. BMC Mol. Biol. 2001, 2(1), 15.
227. Lugli, A.; Spichtin, H.; Maurer, R.; Mirlacher, M.; Kiefer, J.; Huusko, P.; Azorsa, D.; Terracciano, L.; Sauter, G.; Kallioniemi, O. P.; Mousses, S.; Tornillo, L. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers. Clin. Cancer Res. 2005, 11(18), 6450-6458.
228. Batlle, E.; Bacani, J.; Begthel, H.; Jonkheer, S.; Gregorieff, A.; van de Born, M.; Malats, N.; Sancho, E.; Boon, E.; Pawson, T.; Gallinger, S.; Pals, S.; Clevers, H. EphB receptor activity suppresses colorectal cancer progression. Nature 2005, 435(7045), 1126-1130.
229. Davalos, V.; Dopeso, H.; Castano, J.; Wilson, A. J.; Vilardell, F.; Romero-Gimenez, J.; Espin, E.; Armengol, M.; Capella, G.; Mariadason, J. M.; Aaltonen, L. A.; Schwartz, S., Jr.; Arango, D. EPHB4 and survival of colorectal cancer patients. Cancer Res. 2006, 66(18), 8943-8948.
230. Noren, N. K.; Lu, M.; Freeman, A. L.; Koolpe, M.; Pasquale, E. B. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc. Natl. Acad. Sci. USA 2004, 101(15), 5583-5588.
231. Erber, R.; Eichelsbacher, U.; Powajbo, V.; Korn, T.; Djonov, V.; Lin, J.; Hammes, H. P.; Grobholz, R.; Ullrich, A.; Vajkoczy, P. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J. 2006, 25(3), 628-641.
232. Cortina, C.; Palomo-Ponce, S.; Iglesias, M.; Fernandez-Masip, J. L.; Vivancos, A.; Whissell, G.; Huma, M.; Peiro, N.; Gallego, L.; Jonkheer, S.; Davy, A.; Lloreta, J.; Sancho, E.; Batlle, E. EphBephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat. Genet. 2007, 39(11), 1376-1383.
233. Wang, J.; Kataoka, H.; Suzuki, M.; Sato, N.; Nakamura, R.; Tao, H.; Maruyama, K.; Isogaki, J.; Kanaoka, S.; Ihara, M.; Tanaka, M.; Kanamori, M.; Nakamura, T.; Shinmura, K.; Sugimura, H. Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene 2005, 24(36), 5637-5647.
234. Alazzouzi, H.; Davalos, V.; Kokko, A.; Domingo, E.; Woerner, S. M.; Wilson, A. J.; Konrad, L.; Laiho, P.; Espin, E.; Armengol, M.; Imai, K.; Yamamoto, H.; Mariadason, J. M.; Gebert, J. F.; Aaltonen, L. A.; Schwartz, S., Jr.; Arango, D. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. Cancer Res. 2005, 65(22), 10170-10173.
235. Kaidi, A.; Moorghen, M.; Williams, A. C.; Paraskeva, C. Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia? Gut 2007, 56(11), 1637-1638.
236. Vihanto, M. M.; Plock, J.; Erni, D.; Frey, B. M.; Frey, F. J.; Huynh-Do, U. Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J. 2005, 19(12), 1689-1691.
237. Martin-Rendon, E.; Hale, S. J.; Ryan, D.; Baban, D.; Forde, S. P.; Roubelakis, M.; Sweeney, D.; Moukayed, M.; Harris, A. L.; Davies, K.; Watt, S. M. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells 2007, 25(4), 1003-1012.
238. Wicks, I. P.; Wilkinson, D.; Salvaris, E.; Boyd, A. W. Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines. Proc. Natl. Acad. Sci. USA 1992, 89(5), 1611-1615.
239. Bennett, B. D.; Wang, Z.; Kuang, W. J.; Wang, A.; Groopman, J. E.; Goeddel, D. V.; Scadden, D. T. Cloning and characterization of HTK, a novel transmembrane tyrosine kinase of the EPH subfamily. J. Biol. Chem. 1994, 269(19), 14211-14218.
240. Fu, X.; McGrath, S.; Pasillas, M.; Nakazawa, S.; Kamps, M. P. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1. Oncogene 1999, 18(35), 4920-4929.
241. Luo, H.; Wan, X.; Wu, Y.; Wu, J. Cross-linking of EphB6 resulting in signal transduction and apoptosis in Jurkat cells. J. Immunol. 2001, 167(3), 1362-1370.
242. Nakanishi, H.; Nakamura, T.; Canaani, E.; Croce, C. M. ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias. Proc. Natl. Acad. Sci. USA 2007, 104(36), 14442-14447.
243. Nagayama, S.; Katagiri, T.; Tsunoda, T.; Hosaka, T.; Nakashima, Y.; Araki, N.; Kusuzaki, K.; Nakayama, T.; Tsuboyama, T.; Nakamura, T.; Imamura, M.; Nakamura, Y.; Toguchida, J. Genomewide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res. 2002, 62(20), 5859-5866.
244. Barco, R.; Hunt, L. B.; Frump, A. L.; Garcia, C. B.; Benesh, A.; Caldwell, R. L.; Eid, J. E. The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway. Mol. Biol. Cell 2007, 18(10), 4003-4012.
245. Dottori, M.; Down, M.; Huttmann, A.; Fitzpatrick, D. R.; Boyd, A. W. Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells. Blood 1999, 94(7), 2477-2486.
246. Cilloni, D.; Catalano, R.; Chiarenza, A.; Messa, F.; Carturan, S.; Arruga, F.; Defilippi, I.; Rosso, V.; Nicoli, P.; Messa, E.; Martinelli, G.; Lackmann, M.; Bracco, E.; Saglio, G. EphA3 is abnormally expressed in chronic myeloprolipherative disorders and can be targeted by dasatinib or by monoclonal antibodies. Haematologica 2007, 92, 248-249.
247. Boyd, A. W.; Ward, L. D.; Wicks, I. P.; Simpson, R. J.; Salvaris, E.; Wilks, A.; Welch, K.; Loudovaris, M.; Rockman, S.; Busmanis, I. Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line. J. Biol. Chem. 1992, 267(5), 3262-3267.
248. Vearing, C.; Lee, F. T.; Wimmer-Kleikamp, S.; Spirkoska, V.; To, C.; Stylianou, C.; Spanevello, M.; Brechbiel, M.; Boyd, A. W.; Scott, A. M.; Lackmann, M. Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. Cancer Res. 2005, 65(15), 6745-6754.
249. Easty, D. J.; Hill, S. P.; Hsu, M. Y.; Fallowfield, M. E.; Florenes, V. A.; Herlyn, M.; Bennett, D. C. Up-regulation of ephrin-A1 during melanoma progression. Int.J. Cancer 1999, 84(5), 494-501.
250. Hess, A. R.; Margaryan, N. V.; Seftor, E. A.; Hendrix, M. J. Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: Role of the Eph receptors. Dev. Dyn. 2007, 236(12), 3283-3296.
251. De Bellard, M. E.; Ching, W.; Gossler, A.; Bronner-Fraser, M. Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. Dev. Biol. 2002, 249(1), 121-130.
252. McLennan, R.; Krull, C. E. Ephrin-as cooperate with EphA4 to promote trunk neural crest migration. Gene Exp. 2002, 10(5-6), 295-305.
253. Santiago, A.; Erickson, C. A. Ephrin-B ligands play a dual role in the control of neural crest cell migration. Development 2002, 129(15), 3621-3632.
254. Meyer, S.; Hafner, C.; Guba, M.; Flegel, S.; Geissler, E. K.; Becker, B.; Koehl, G. E.; Orso, E.; Landthaler, M.; Vogt, T. Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. Int. J. Oncol. 2005, 27(5), 1197-1206.
255. Vogt, T.; Stolz, W.; Welsh, J.; Jung, B.; Kerbel, R. S.; Kobayashi, H.; Landthaler, M.; McClelland, M. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin. Cancer. Res. 1998, 4(3), 791-797.
256. Hendrix, M. J.; Seftor, E. A.; Hess, A. R.; Seftor, R. E. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 2003, 3(6), 411-421.
257. Walker-Daniels, J.; Hess, A. R.; Hendrix, M. J.; Kinch, M. S. Differential regulation of EphA2 in normal and malignant cells. Am. J. Pathol. 2003, 162(4), 1037-1042.
258. Ireton, R. C.; Chen, J. EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics. Curr. Cancer Drug Targets 2005, 5(3), 149-157.
259. Hess, A. R.; Seftor, E. A.; Gardner, L. M.; Carles-Kinch, K.; Schneider, G. B.; Seftor, R. E.; Kinch, M. S.; Hendrix, M. J. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res. 2001, 61(8), 3250-3255.
260. Brantley, D. M.; Cheng, N.; Thompson, E. J.; Lin, Q.; Brekken, R. A.; Thorpe, P. E.; Muraoka, R. S.; Cerretti, D. P.; Pozzi, A.; Jackson, D.; Lin, C.; Chen, J. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 2002, 21(46), 7011-7026.
261. Cheng, N.; Brantley, D.; Fang, W. B.; Liu, H.; Fanslow, W.; Cerretti, D. P.; Bussell, K. N.; Reith, A.; Jackson, D.; Chen, J. Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia 2003, 5(5), 445-456.
262. Koolpe, M.; Burgess, R.; Dail, M.; Pasquale, E. B. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J. Biol. Chem. 2005, 280(17), 17301-17311.
263. Koolpe, M.; Dail, M.; Pasquale, E. B. An ephrin mimetic peptide that selectively targets the EphA2 receptor. J. Biol. Chem. 2002, 277(49), 46974-46979.
264. Coffman, K. T.; Hu, M.; Carles-Kinch, K.; Tice, D.; Donacki, N.; Munyon, K.; Kifle, G.; Woods, R.; Langermann, S.; Kiener, P. A.; Kinch, M. S. Differential EphA2 epitope display on normal versus malignant cells. Cancer Res. 2003, 63(22), 7907-7912.
265. Yamaguchi, S.; Tatsumi, T.; Takehara, T.; Sakamori, R.; Uemura, A.; Mizushima, T.; Ohkawa, K.; Storkus, W. J.; Hayashi, N. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines. Cancer 2007, 110(7), 1469-1477.
266. Adams, G. P.; Weiner, L. M. Monoclonal antibody therapy of cancer. Nat. Biotechnol. 2005, 23(9), 1147-1157.
267. Carles-Kinch, K.; Kilpatrick, K. E.; Stewart, J. C.; Kinch, M. S. Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res. 2002, 62(10), 2840-2847.